Literature DB >> 16978540

Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis.

Dong Liang1, Wenfeng Ma, Cuiwei Yao, Huafeng Liu, Xiaowen Chen.   

Abstract

To evaluate the balance status of interleukin 18 (IL-18) and interleukin 18 binding protein (IL-18BP) in circulation in patients with lupus nephritis (LN) and primary nephrotic syndrome (PNS), plasma levels as well as mRNA expression in peripheral blood mononuclear cells (PBMCs) of IL-18 and IL-18BP were measured by ELISA and RT-PCR respectively. The ratio of IL-18/IL-18BP was also calculated. Both plasma IL-18 and IL-18BP increased significantly in LN patients while only IL-18BP increased in PNS, which resulted in an elevated ratio of IL-18/IL-18BP in LN but not in PNS patients when compared with normal controls. In contrast, increased level of IL-18 mRNA was only detected in LN but not in PNS group, although IL-18BP mRNA expressions in PBMCs in both groups were higher than that in control. The imbalance of IL-18 and IL-18BP might be involved in the pathogenesis of LN, based on which a therapeutic approach is valuable to be developed for LN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978540

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  10 in total

1.  Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients.

Authors:  Dawei Hu; Xiaoqian Liu; Shunle Chen; Chunde Bao
Journal:  Clin Rheumatol       Date:  2010-02-08       Impact factor: 2.980

Review 2.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

3.  Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus.

Authors:  Lijun Song; Feng Qiu; Yuchen Fan; Feng Ding; Huaxiang Liu; Qiang Shu; Weiwei Liu; Xingfu Li
Journal:  J Clin Immunol       Date:  2012-09-09       Impact factor: 8.317

Review 4.  Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE).

Authors:  Claudio Ponticelli; Gabriella Moroni
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20

Review 5.  Structural Basis of IL-1 Family Cytokine Signaling.

Authors:  James K Fields; Sebastian Günther; Eric J Sundberg
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

6.  Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia.

Authors:  Yanxia Zhan; Luya Cheng; Boting Wu; Lili Ji; Pu Chen; Feng Li; Jingjing Cao; Yang Ke; Ling Yuan; Zhihui Min; Lihua Sun; Hao Chen; Fanli Hua; Yunfeng Cheng
Journal:  Ann Transl Med       Date:  2021-02

Review 7.  Interleukin-18 in Inflammatory Kidney Disease.

Authors:  Yasuaki Hirooka; Yuji Nozaki
Journal:  Front Med (Lausanne)       Date:  2021-03-01

Review 8.  Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis-A Literature Review.

Authors:  Olga M Koper-Lenkiewicz; Kinga Sutkowska; Natalia Wawrusiewicz-Kurylonek; Ewa Kowalewska; Joanna Matowicka-Karna
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

9.  Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus.

Authors:  Mohammad Reza Hatef; Maryam Sahebari; Zahra Rezaieyazdi; Mohammad Reza Nakhjavani; Mahmoud Mahmoudi
Journal:  ISRN Rheumatol       Date:  2013-03-14

10.  Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis.

Authors:  R Mora-Buch; I Dotti; N Planell; E Calderón-Gómez; P Jung; M C Masamunt; J Llach; E Ricart; E Batlle; J Panés; A Salas
Journal:  Mucosal Immunol       Date:  2015-11-04       Impact factor: 7.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.